Objective To explore the diagnostic value of fractionated exhaled nitric oxide(Fe NO)measurement in patients with asthma-chronic obstructive pulmonary disease(COPD)overlap syndrome(ACOS).Methods Eightyone patients with ACOS,76 patients with asthma,82 patients with COPD and 39 healthy non-smoking subjects